DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for CytRx Corporation (CYTR)
« Back to company indexCYTR Chatter Timeline
Stock Ticker for CYTR
Most Active Tweeters for CYTR
| User | Tweets |
|---|---|
| @dispatchtribune | 1 |
Recent Tweets for CYTR
 |
@dispatchtribune CytRx $CYTR Share Price Passes Above Two Hundred Day Moving Average of $0.41 https://t.co/5FNuBSu3ay September 13th 2019, 7:09pm |
 |
@TheMarketsDaily CytRx $CYTR Issues Quarterly Earnings Results https://t.co/IaDL1p2snL August 10th 2019, 6:08pm |
 |
@bbnsnews CytRx $CYTR Releases Earnings Results, Beats Expectations By $0.02 EPS https://t.co/zmilHpCuR8 August 10th 2019, 5:08pm |
 |
@AmericanBanking CytRx $CYTR Posts Earnings Results, Beats Expectations By $0.02 EPS https://t.co/EPNWncikbC #stocks August 10th 2019, 1:08pm |
 |
@confcalltran CytRx Corporation Just Filed Its Quarterly Report: 5. Basic and Diluted... https://t.co/LsWUtj6l4d $CYTR August 9th 2019, 6:08am |
|
@AmericanBanking -$0.06 Earnings Per Share Expected for CytRx Co. $CYTR This Quarter https://t.co/7bjJIKMn5X #stocks August 8th 2019, 10:08pm |
|
@AmericanBanking CytRx $CYTR & Neon Therapeutics $NTGN Head to Head Analysis https://t.co/fObt3pKIsf #stocks August 6th 2019, 8:08pm |
 |
@WeekHerald CytRx $CYTR & Neon Therapeutics $NTGN Head to Head Analysis https://t.co/iaBwfu2fTA August 6th 2019, 8:08pm |
 |
@ThisLincolnian Neon Therapeutics $NTGN & CytRx $CYTR Head to Head Analysis https://t.co/7nFmP1STen August 6th 2019, 8:08pm |
|
@WeekHerald CytRx $CYTR Upgraded to “Buy” at ValuEngine https://t.co/ip4rSGmPAw August 5th 2019, 4:08am |
 |
@TickerReport CytRx $CYTR Stock Rating Upgraded by ValuEngine https://t.co/yREJkzI6aj August 5th 2019, 4:08am |
 |
@dailypoliticaln CytRx $CYTR Upgraded to Buy by ValuEngine https://t.co/r6TcXBdKuh August 2nd 2019, 10:08pm |
 |
@ZolmaxNews CytRx $CYTR Share Price Passes Above 200 Day Moving Average of $0.00 https://t.co/34hk7jZcva July 26th 2019, 5:07pm |
|
@ZolmaxNews -$0.06 Earnings Per Share Expected for CytRx Co. $CYTR This Quarter https://t.co/v7CgB0ayAe July 22nd 2019, 1:07pm |
 |
@amystocks21334 whytestocks: Penny Stock Millionaires: $CYTR News Article - CytRx Corporation Highlights https://t.co/vrcA10psYz July 22nd 2019, 9:07am |
|
@AmericanBanking CytRx Co. $CYTR Expected to Post Earnings of -$0.06 Per Share https://t.co/5qymLhPUzN #stocks July 17th 2019, 9:07am |
|
@ZolmaxNews Analyzing Spark Therapeutics $ONCE and CytRx $CYTR https://t.co/6gtPdgPZmE July 4th 2019, 4:07am |
|
@TickerReport Spark Therapeutics $ONCE and CytRx $CYTR Head-To-Head Comparison https://t.co/SnhxXFpTWw July 2nd 2019, 3:07am |
|
@dispatchtribune Spark Therapeutics $ONCE and CytRx $CYTR Financial Comparison https://t.co/khRB34iLLx July 2nd 2019, 3:07am |
|
@TickerReport CytRx Co. $CYTR Expected to Announce Earnings of -$0.06 Per Share https://t.co/kbLDv8HU26 June 29th 2019, 3:06pm |
 |
@IRAMarketReport -$0.06 Earnings Per Share Expected for CytRx Co. $CYTR This Quarter https://t.co/5at9rTskkv #markets June 29th 2019, 3:06pm |
 |
@chaffeybreeze -$0.06 Earnings Per Share Expected for CytRx Co. $CYTR This Quarter https://t.co/I81USvdO7D #stocks June 29th 2019, 3:06pm |
 |
@StockNewsNow $CYTR #VIDEO: CytRx Corporation - Biopharmaceutical Company Discusses Near Term Value from Out-License Deals and Gr… https://t.co/UJ1860QSZW June 27th 2019, 8:06am |
|
@StockNewsNow $CYTR CytRx Corporation Highlights Patent Issued for New Aldoxorubicin Formulation https://t.co/LMcaC2qWgW June 26th 2019, 1:06pm |
 |
@NewsQuantified $CYTR Highlights Patent Issued for New Aldoxorubicin Formulation, stock shoots +9.38% #CytRx https://t.co/ChKFevtNkF June 26th 2019, 10:06am |
 |
@fintel_io $CYTR / CytRx files form 8-K https://t.co/KgrX7qzK46 - Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits June 26th 2019, 9:06am |
 |
@Allstocknews $CYTR New Form DEF 14A for CytRx Corporation From our Stock News Alerts App June 26th 2019, 6:06am |
|
@Allstocknews $CYTR New Form 25-NSE for CytRx Corporation From our Stock News Alerts App June 24th 2019, 9:06am |
|
@AmericanBanking CytRx Co. $CYTR Expected to Announce Earnings of -$0.06 Per Share https://t.co/p0kqd4DVje #stocks June 24th 2019, 6:06am |
|
@StockNewsNow $CYTR CytRx Corporation Highlights Arimoclomol Licensee Orphazyme A/S to Prepare Regulatory Submission in Europe fo… https://t.co/TfvCPdqOdr June 19th 2019, 1:06pm |
 |
@otc_watch_news $CYTR #OTCQB CytRx Corp. (CYTR: OTCQB) | CytRx Corporation Highlights Arimoclomol Licensee Orphazyme A/S to Prepare… https://t.co/vfZATh1B7t June 19th 2019, 12:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.